Arve Capital

RRW invests in outstanding European Tech companies. We promote their international take-off by providing significant financial firepower and game changing hands-on support in Europe & the US. Backing EU talents in the US Red River West was created to bring active support to outstanding European Tech Companies that have something unique to bring to the US market and transform them into US and Global successes. Within the team, we all share a track record of building and backing start-ups which became global leaders through EU to US expansion. We see our mission of backing European talents into US and Global successes as of strong impact. Europe is indeed home to a talented, driven pool of highly educated engineers and creative entrepreneurs. But the unfamiliarity with the US market means that too many promising European start-ups do not realize their full potential. US success doesn’t just mean bigger scale and more capital: translating Europe-based talent into US success requires expertise, commitment, and a deep understanding of the different business cultures. Narrow, hands-on portfolio strategy In the way we operate as investors and partners, we fully align with the success of the entrepreneurs we back. We have indeed a narrow portfolio strategy : we invest in only circa 10 companies per fund. It makes it possible for our team to dedicate plenty of time to the success of each entrepreneurs and truly provide game-changing hands-on support on both continents. This approach is really unique in VC and those differentiated foundations have been driving and fuelling our operating and ESG approach since day 1. Real-world impact We see our mission of backing European talents into US and Global successes as of strong impact by design. Europe is indeed home to talented and driven pool of top engineers and creative entrepreneurs, but they too often miss the familiarity needed with the US to scale globally. Additionally, we believe the Tech segments & models we invest in present huge opportunities to serve ESG global concerns, therefore investing in founders that care about their impact is one of our 5 core investment criteria. We have integrated environmental, social and governance best practices in numerous aspects of our own organization, including our proprietary sourcing platform. Bringing support on three ESG pillars Our latest fund RRW II Growth is classified under Article 8 of SFDR regulation, as a financial product that promotes, among other things, environmental or social characteristics. We decided to focus our efforts on three ESG subjects: Ethical Technology People Well-being Carbon Reduction We are convinced that those challenges fully align with our performance as a leading EU to US Tech investor; and this is our differentiated narrow portfolio strategy and operating DNA that allows us to act as dedicated and impactful partners on those three ESG pillars.

We back outstanding entrepreneurs and their ideas with capital and Healthcare-specific expertise to create European champions. Therefore, we seek Pre-seed, Seed and Series A investment opportunities across Europe. We are a venture capital firm with deep roots at Europe’s leading tech hub Munich and a unique setup of seasoned Serial Entrepreneurs, Venture Capital Investors and Private Equity Professionals. UNIQUE SECTOR-FOCUSED VC FUND BACKING EUROPE’S HEALTH TECH DISRUPTORS We are focused on venture capital investments in Europe’s health tech challengers. We are passionate about companies that make a lasting impact on Europe’s healthcare system by boosting efficiency and transparency, make living healthy easier, and enable constant change for improved healthcare. Our deep healthcare expertise coupled with a collaborative style of developing a personal connection with each and every one of our portfolio companies allows us to accelerate growth without interfering with the entrepreneurial freedom of our founders. Get in touch with us when you’re ready to learn more; we can’t wait to meet you! The healthcare industry, one of societies most crucial ecosystems, is going through a process of change where daring tech founders of today will shape the healthcare system of tomorrow. We are convinced that the Covid-19 pandemic has triggered a wave of innovation in the Health Tech market and therefore we strive to equip founders with the right resources to reach their goal in riding the health tech wave. OUR INVESTMENT FOCUSFounding & Early Stage: We help mission driven founders to build a company at an early-stage. We support you with capital, deep healthcare and regulatory expertise, co-founder access and firm development resources starting at the (Pre)-Seed or Series A stage of your company. Growth Stage: We have the appropriate financial and firm development resources to back our early-stage founders through the extended growth stages of their companies development. Further, we engage in selective initial investments into growth stage firms. MEANING OF YZR YZR is pronounced as [ˈwaɪzər]. It is a blend of ‘wise’ and ‘Isar’ reflecting two core aspects of our values: Our investment approach is backed by unique healthcare expertise, therefore allowing us to take wise & informed investment decisions. The river ‘Isar‘ is a symbol for Munich and reflects our roots, heritage and connection with Europe’s deep tech epicenter.

LUMO Labs is an impact-driven multi-stage (pre-seed through series A) capital fund with a two-year venture builder program for founding teams of ventures focused on AI/Data, Blockchain, Robotics/Drones, IoT, and/or VR/AR. We believe these emerging technologies hold the key to solving the social challenges people face today. At LUMO Labs, we focus on sustainable cities and communities, health and wellbeing and quality education. We create opportunities for people and emerging technologies by connecting impact-driven groundbreaking start-ups to our funds, our expertise, our network and each other.

We support start-ups with investments between $10M and $20M in Europe, Israel and opportunistically on the East coast of the US. Forestay is more than just a VC fund, it’s a family. Forestay was founded as the digital tech arm of a family-oriented investment group that traces its successes in business and its enduring values back across generations. The Bertarelli family founded B-FLEXION (formerly Waypoint Capital), of which Forestay is a part, in 2012 to evolve the management of the capital realised by the sale of Serono, the global leader in biotech and healthcare that they had grown over three generations of leadership. In the decade since, B-FLEXION and its businesses have generated exceptional and lasting value. B-FLEXION is an entrepreneurial private investment firm that partners with sophisticated capital to deliver exceptional value over the generations. As well as its investment funds seeding and building businesses in technology, private equity, real estate and hedge funds, B-FLEXION also focuses on growing operating businesses in transformative industries. Building on its heritage and of that of its founder and Chairman, these have been principally in life sciences, healthcare and digital health.

Mangrove Capital Partners is a contrarian, bold and patient venture capital firm. We have had the privilege of being early backers of 6 unicorns: Skype, Wix, Flo Health, WalkMe, K Health and TBOL. Our key tenets that have driven our success include performance, diversity and commitment to employee stock options. Our geographical focus is on Europe and Israel and we deploy our capital evenly among these two areas: Europe and Israel.

WENVEST Capital is a private investment firm and emerged to become an entrepreneurial minded Venture Capital investor for Growth. The team of WENVEST Capital is dedicated to support the digital leaders of tomorrow with capital, know-how and network. We are based in Munich and are looking for investment opportunities primarily in the GAS region. STRATEGY & INVESTMENT CRITERIA We are entrepreneurial minded investors and partners, investing into pre-growth and growth companies, typically around Seed phase. With our first investment into a company, we usually invest in the range of EUR 0.25m to EUR 1.0m and reserve further capital for future financing rounds (we are flexible to join an existing consortium or lead a financing round). From joining your board, to supporting in future fundraising, strategic & operational sparring or hiring, we can be your partner of choice. Note: Our initial check size does not correlate with investment phase and is excluding of any follow-on commitments. Areas of Investment in B2B Technology Digital Transformation Next generation of Financial Instituions & Governance Business process optimization & increased productivity Cloud based solutions around Data & AI Digital Health Digital health solutions & healthcare system revolution FoodTech & healthy living Climate Solutions Enabler for CO2 reduction across industries Waste reduction & alternative resources Solutions towards reporting, monitoring and offsetting Further Investment Criteria First Revenues and Proof of Concept Significant USP and Defensible Technology Excellent Founder and Management Team Scalability Potential